Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC647055 + Simeprevir +/- GSK2336805 in Chronic HCV GT1
NCT01724086Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2012
- Primary completion
- Sep 2014
- Modality
- Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of TMC-647055 in hepatitis C (HCV), sponsored by Janssen Pharmaceutical. Started Oct 2012; status: completed.
02
Drugs
TMC-647055
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01724086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724086.